【报告】把脉医美市场发展趋势 洞见医美消费多元场景(英)

Men of Insight See the Trend,while Men of Wisdom Ride itChina Medical Aesthetic Industry Outlook 2023May 20232PrefaceThe year 2022 is set to be a remarkable one for medical aesthetics and could have a profound impact on the industry as a whole.As a company deeply involved in medical aesthetics, Allergan Aesthetics not only continues to innovate and promote the healthy development of the industry, but also closely monitors the subtle changes. In 2023, Allergan Aesthetics has again collaborated with Deloitte Consulting to publish “China Medical Aesthetic Industry Outlook 2023,” providing insights from the dimension of the status quo and outlook, consumption trends, and city portraits. With the haze of the pandemic gradually dissipating and several favorable measures implemented, driven by the growing market size and demand, Allergan Aesthetics still maintains a positive view on the rapid development of China’s medical aesthetics. Allergen Aesthetics is committed to our mission and responsibility to facilitate the promising development of China’s medical aesthetic market.Allergan Aesthetics hopes to dedicate this report to all aspiring medical aesthetic colleagues and thus promotes the development in a cooperativemanner.In post-epidemic era, the Chinese government has taken measures to promote consumption and economic growth, emphasizing high-quality development of the healthcare industry. In line with the national development trend, Deloitte Consulting has long been focusing on the consumer healthcare sector with timely monitor and hopes to promote the healthy and sustainable development of the industry.To further grasp the pulse of industry, Deloitte Consulting and Allergan Aesthetics have partnered again to launch “China Medical Aesthetic Industry Outlook 2023” with upgrading resource investment. On top of last year’s report, this report expands the depth and breadth of the research coverage, focuses on changes in institutional operation, channel, and consumption trends, it is found that institutions pay more attention to profitability and product safety while consumers are pursing more personalized and lean concepts, providing insights into the future development of medical aesthetic market.We hope this report will bring forth the new ideas and facilitate the industry’s benign and high-quality development.Carrie XiaoDeloitte Consulting China Life Sciences Industry LeaderEthan QiuAllergan Aesthetics ChinaGeneral ManagerExecutive SummaryThis report provides insights on China medical aesthetics market outlook, consumption trends and insights into the operational status of institutions, and city portraits based on primary research and surveys conducted with 2,000+ consumers and 600+ medical aesthetic institutions2023 is the transformative year for China to emerge from the haze of the pandemic, the trend of recovering consumer confidence and willingness to pay is observed in medical aesthetics market as wellChina medical aesthetics market outlookChin

立即下载
医药生物
2023-05-30
85页
4.21M
收藏
分享

【报告】把脉医美市场发展趋势 洞见医美消费多元场景(英),点击即可下载。报告格式为PDF,大小4.21M,页数85页,欢迎下载。

本报告共85页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
本报告共85页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
水滴研报所有报告均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
相关图表
图4—Ⅲ期临床实验招募人数差距
医药生物
2023-05-30
来源:2023年全球生命科学行业展望
查看原文
图3—种族失实陈述示例
医药生物
2023-05-30
来源:2023年全球生命科学行业展望
查看原文
图2— 2040年医疗不公平成本模型
医药生物
2023-05-30
来源:2023年全球生命科学行业展望
查看原文
图1—四个行动领域
医药生物
2023-05-30
来源:2023年全球生命科学行业展望
查看原文
图2—数字化成熟度高的生物制药公司最有可能探索新的运营方式(与处于数字化应用发展中或早期阶段的企业相比)
医药生物
2023-05-30
来源:2023年全球生命科学行业展望
查看原文
图3—临床试验中的成本动因
医药生物
2023-05-30
来源:2023年全球生命科学行业展望
查看原文
回顶部
报告群
公众号
小程序
在线客服
收起